Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 11, 2020

SELL
$22.1 - $30.8 $1.06 Million - $1.48 Million
-47,900 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$24.09 - $32.18 $1.15 Million - $1.54 Million
47,900 New
47,900 $1.15 Million
Q1 2019

May 07, 2019

SELL
$12.81 - $19.82 $317,982 - $491,991
-24,823 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$11.47 - $18.71 $284,719 - $464,438
24,823 New
24,823 $327,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.05B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Spark Investment Management LLC Portfolio

Follow Spark Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spark Investment Management LLC with notifications on news.